| Breakdown | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 3.09B | 2.99B | 2.97B | 2.94B | 2.22B |
| Gross Profit | 1.29B | 412.00M | 1.16B | 1.89B | 242.20M |
| EBITDA | 328.70M | 289.30M | 272.20M | 182.90M | 178.60M |
| Net Income | 142.70M | 142.30M | 89.40M | 46.00M | 56.50M |
Balance Sheet | |||||
| Total Assets | 1.83B | 1.79B | 1.68B | 1.70B | 1.45B |
| Cash, Cash Equivalents and Short-Term Investments | 281.50M | 202.70M | 151.40M | 101.10M | 82.70M |
| Total Debt | 310.40M | 334.60M | 388.70M | 400.00M | 276.00M |
| Total Liabilities | 1.18B | 1.19B | 1.16B | 1.21B | 1.01B |
| Stockholders Equity | 641.40M | 593.70M | 515.30M | 494.50M | 439.90M |
Cash Flow | |||||
| Free Cash Flow | 171.60M | 176.90M | 102.50M | -26.90M | 71.30M |
| Operating Cash Flow | 261.90M | 265.90M | 197.00M | 54.80M | 155.70M |
| Investing Cash Flow | -75.20M | -57.70M | -72.50M | -89.00M | -97.00M |
| Financing Cash Flow | -110.60M | -145.20M | -67.70M | 41.00M | -37.60M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
80 Outperform | £1.51B | 3.78 | 23.46% | 3.08% | -1.17% | 12.31% | |
78 Outperform | £500.74M | 11.49 | 14.87% | 1.88% | -12.98% | 5.51% | |
74 Outperform | £4.01B | 13.49 | 23.73% | 1.80% | 9.97% | -15.46% | |
73 Outperform | £2.28B | 12.50 | 24.53% | 2.49% | 6.93% | 21.50% | |
72 Outperform | £527.40M | 7.10 | 30.23% | 3.65% | 5.78% | -6.80% | |
71 Outperform | £911.68M | 9.81 | 11.69% | 3.19% | 4.40% | 31.59% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% |